Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregers G Hermann

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Biological Procedures Online|November 12, 2013
Exploration of two methods for quantitative Mitomycin C measurement in tumor tissue in vitro and in vivoLee Mackenzie Fischer, Juan Luis Vásquez, Julie Gehl, et al.
Plos One|October 12, 2012
Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylationThomas Reinert, Michael Borre, Anders Christiansen, et al.
The Journal of Urology|December 29, 2025
In-office laser coagulation of Ta bladder tumor compared to TUR-BT: 12 months follow-up randomized clinical trialGyrithe L Pedersen, Karin Mogensen, Susanne Rosthøj, et al.
The Journal of Urology|June 18, 2026
Reply: Clinical Decision-Making Beyond Noninferiority in Office-Based Treatment of Recurrent Low-Grade Ta Bladder TumorsGyrithe L Pedersen, Karin Mogensen, Susanne Rosthøj, et al.
Scandinavian Journal of Urology|May 25, 2017
Non-muscle-invasive bladder cancer: a vision for the futurePer-Uno Malmström, Sachin Agrawal, Mats Bläckberg, et al.
Scandinavian Journal of Urology and Nephrology|November 18, 2011
Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidancePer-Uno Malmström, Magnus Grabe, Erik Skaaheim Haug, et al.
European Urology|December 24, 2014
Health economic changes as a result of implementation of targeted therapy for metastatic renal cell carcinoma: national results from DARENCA study 2Anne V Soerensen, Frede Donskov, Jakob Kjellberg, et al.
Scandinavian Journal of Urology|February 14, 2014
Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centreTrine Honnens De Lichtenberg, Gregers G Hermann, Mikael Rørth, et al.
Cancers|September 28, 2024
Raman Spectroscopy for Instant Bladder Tumor Diagnosis: System Development and In Vivo Proof-Of-Principle Study in Accordance with the European Medical Device Regulation (MDR2017/745)Ines Latka, Karin Mogensen, Florian Knorr, et al.
Journal of Biophotonics|October 17, 2019
Bladder tissue characterization using probe-based Raman spectroscopy: Evaluation of tissue heterogeneity and influence on the model predictionEliana Cordero, Jan Rüger, Dominik Marti, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Biological Procedures Online|November 12, 2013
Exploration of two methods for quantitative Mitomycin C measurement in tumor tissue in vitro and in vivoLee Mackenzie Fischer, Juan Luis Vásquez, Julie Gehl, et al.
Plos One|October 12, 2012
Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylationThomas Reinert, Michael Borre, Anders Christiansen, et al.
The Journal of Urology|December 29, 2025
In-office laser coagulation of Ta bladder tumor compared to TUR-BT: 12 months follow-up randomized clinical trialGyrithe L Pedersen, Karin Mogensen, Susanne Rosthøj, et al.
The Journal of Urology|June 18, 2026
Reply: Clinical Decision-Making Beyond Noninferiority in Office-Based Treatment of Recurrent Low-Grade Ta Bladder TumorsGyrithe L Pedersen, Karin Mogensen, Susanne Rosthøj, et al.
Scandinavian Journal of Urology|May 25, 2017
Non-muscle-invasive bladder cancer: a vision for the futurePer-Uno Malmström, Sachin Agrawal, Mats Bläckberg, et al.
Scandinavian Journal of Urology and Nephrology|November 18, 2011
Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidancePer-Uno Malmström, Magnus Grabe, Erik Skaaheim Haug, et al.
European Urology|December 24, 2014
Health economic changes as a result of implementation of targeted therapy for metastatic renal cell carcinoma: national results from DARENCA study 2Anne V Soerensen, Frede Donskov, Jakob Kjellberg, et al.
Scandinavian Journal of Urology|February 14, 2014
Overall survival after immunotherapy, tyrosine kinase inhibitors and surgery in treatment of metastatic renal cell cancer: outcome of 143 consecutive patients from a single centreTrine Honnens De Lichtenberg, Gregers G Hermann, Mikael Rørth, et al.
Cancers|September 28, 2024
Raman Spectroscopy for Instant Bladder Tumor Diagnosis: System Development and In Vivo Proof-Of-Principle Study in Accordance with the European Medical Device Regulation (MDR2017/745)Ines Latka, Karin Mogensen, Florian Knorr, et al.
Journal of Biophotonics|October 17, 2019
Bladder tissue characterization using probe-based Raman spectroscopy: Evaluation of tissue heterogeneity and influence on the model predictionEliana Cordero, Jan Rüger, Dominik Marti, et al.
Pageof 4